Revisions of General Guidelines for the Preclinical Toxicology of New Cytotoxic Anticancer Agents in Europe

By Cancer Research Campaign CRC Phase I/II Clinical Trials Committee and the European Organization for Research and Treatment of Cancer EORTC New Drug Development Office   Burtles S.S.   Newell D.R.   Henrar R.E.C.   Connors T.A.  

European Journal of Cancer, Vol. 31, Iss. 3, 1995-01 ,pp. : 408-410

Elsevier

Access to resources Recommend Favorite

Editorial (Thematic Issue Role of Heteroaromatics as Anticancer Agents)

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 16, Iss. 10, 2016-08 ,pp. : 1204-1204

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Hot Topic: Recent Development of Molecular Targeted Anti-Cancer Agents)

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 13, Iss. 3, 2013-03 ,pp. : 381-381

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial: Plant Derived Secondary Metabolites as Anti-Cancer Agents

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 13, Iss. 10, 2013-12 ,pp. : 1551-1551

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Thematic Issue: Targeting Anti-Cancer Agents and Cancer Treatments)

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 15, Iss. 7, 2015-01 ,pp. : 806-808

Bentham Science Publishers

Access to resources Recommend Favorite